[1]
A. A. MD, “Post approval changes in generic drug products and marketed drug products according to usfda: a review”, Jour of Mod Tech Bio All Sci, vol. 1, no. 2, pp. 1–7, Dec. 2024, doi: 10.70604/jmtbas.v1i2.20.